Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice.

Wan Y, Bao X, Huang J, Zhang X, Liu W, Cui Q, Jiang D, Wang Z, Liu R, Wang Q.

Front Physiol. 2017 May 15;8:294. doi: 10.3389/fphys.2017.00294. eCollection 2017.

2.

Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides.

Sekar R, Wang L, Chow BK.

Front Endocrinol (Lausanne). 2017 Feb 7;8:18. doi: 10.3389/fendo.2017.00018. eCollection 2017. Review.

3.

Disruption of Glucagon-Like Peptide 1 Signaling in Sim1 Neurons Reduces Physiological and Behavioral Reactivity to Acute and Chronic Stress.

Ghosal S, Packard AEB, Mahbod P, McKlveen JM, Seeley RJ, Myers B, Ulrich-Lai Y, Smith EP, D'Alessio DA, Herman JP.

J Neurosci. 2017 Jan 4;37(1):184-193. doi: 10.1523/JNEUROSCI.1104-16.2016.

PMID:
28053040
4.

The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.

Burmeister MA, Ayala JE, Smouse H, Landivar-Rocha A, Brown JD, Drucker DJ, Stoffers DA, Sandoval DA, Seeley RJ, Ayala JE.

Diabetes. 2017 Feb;66(2):372-384. doi: 10.2337/db16-1102. Epub 2016 Dec 1.

PMID:
27908915
5.

Physiologic and Neural Controls of Eating.

Moran TH, Ladenheim EE.

Gastroenterol Clin North Am. 2016 Dec;45(4):581-599. doi: 10.1016/j.gtc.2016.07.009. Epub 2016 Oct 13. Review.

PMID:
27837774
6.

Liraglutide suppresses obesity and induces brown fat-like phenotype via Soluble Guanylyl Cyclase mediated pathway in vivo and in vitro.

Zhu E, Yang Y, Zhang J, Li Y, Li C, Chen L, Sun B.

Oncotarget. 2016 Dec 6;7(49):81077-81089. doi: 10.18632/oncotarget.13189.

7.

Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control.

Alhadeff AL, Mergler BD, Zimmer DJ, Turner CA, Reiner DJ, Schmidt HD, Grill HJ, Hayes MR.

Neuropsychopharmacology. 2017 Jun;42(7):1471-1479. doi: 10.1038/npp.2016.246. Epub 2016 Oct 26.

PMID:
27782127
8.

Obesity: Current and potential pharmacotherapeutics and targets.

Narayanaswami V, Dwoskin LP.

Pharmacol Ther. 2017 Feb;170:116-147. doi: 10.1016/j.pharmthera.2016.10.015. Epub 2016 Oct 20. Review.

PMID:
27773782
9.

Parabrachial CGRP Neurons Control Meal Termination.

Campos CA, Bowen AJ, Schwartz MW, Palmiter RD.

Cell Metab. 2016 May 10;23(5):811-20. doi: 10.1016/j.cmet.2016.04.006.

10.

GLP-1 influences food and drug reward.

Hayes MR, Schmidt HD.

Curr Opin Behav Sci. 2016 Jun;9:66-70.

11.

GLP-1 and weight loss: unraveling the diverse neural circuitry.

Kanoski SE, Hayes MR, Skibicka KP.

Am J Physiol Regul Integr Comp Physiol. 2016 May 15;310(10):R885-95. doi: 10.1152/ajpregu.00520.2015. Epub 2016 Mar 30. Review.

12.

Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.

Reiner DJ, Mietlicki-Baase EG, McGrath LE, Zimmer DJ, Bence KK, Sousa GL, Konanur VR, Krawczyk J, Burk DH, Kanoski SE, Hermann GE, Rogers RC, Hayes MR.

J Neurosci. 2016 Mar 23;36(12):3531-40. doi: 10.1523/JNEUROSCI.3579-15.2016.

13.

Hindbrain glucagon-like peptide-1 neurons track intake volume and contribute to injection stress-induced hypophagia in meal-entrained rats.

Kreisler AD, Rinaman L.

Am J Physiol Regul Integr Comp Physiol. 2016 May 15;310(10):R906-16. doi: 10.1152/ajpregu.00243.2015. Epub 2016 Mar 2.

14.

Sex and estrogens alter the action of glucagon-like peptide-1 on reward.

Richard JE, Anderberg RH, López-Ferreras L, Olandersson K, Skibicka KP.

Biol Sex Differ. 2016 Jan 16;7:6. doi: 10.1186/s13293-016-0059-9. eCollection 2016.

15.

The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats.

Bernosky-Smith KA, Stanger DB, Trujillo AJ, Mitchell LR, España RA, Bass CE.

Pharmacol Biochem Behav. 2016 Mar;142:48-55. doi: 10.1016/j.pbb.2015.12.007. Epub 2015 Dec 15.

16.

Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine.

Schmidt HD, Mietlicki-Baase EG, Ige KY, Maurer JJ, Reiner DJ, Zimmer DJ, Van Nest DS, Guercio LA, Wimmer ME, Olivos DR, De Jonghe BC, Hayes MR.

Neuropsychopharmacology. 2016 Jun;41(7):1917-28. doi: 10.1038/npp.2015.362. Epub 2015 Dec 17.

17.

CCK Response Deficiency in Synphilin-1 Transgenic Mice.

Smith WW, Smith M, Yang D, Choi PP, Moghadam A, Li T, Moran TH.

PLoS One. 2015 Nov 16;10(11):e0142314. doi: 10.1371/journal.pone.0142314. eCollection 2015.

18.

Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea.

De Jonghe BC, Holland RA, Olivos DR, Rupprecht LE, Kanoski SE, Hayes MR.

Physiol Behav. 2016 Jan 1;153:109-14. doi: 10.1016/j.physbeh.2015.10.031. Epub 2015 Nov 7.

19.

Mice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity.

Takagi Y, Kinoshita K, Ozaki N, Seino Y, Murata Y, Oshida Y, Hayashi Y.

PLoS One. 2015 Sep 17;10(9):e0138322. doi: 10.1371/journal.pone.0138322. eCollection 2015.

20.

The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.

Fortin SM, Chartoff EH, Roitman MF.

Neuropsychopharmacology. 2016 Feb;41(3):906-15. doi: 10.1038/npp.2015.220. Epub 2015 Jul 27.

Supplemental Content

Support Center